Spectrum Pharmaceuticals
Henderson
About Spectrum Pharmaceuticals
Spectrum Pharmaceuticals is a biopharmaceutical company that focuses on acquiring, developing, and commercializing novel and targeted drug products, with a primary focus on oncology. It has a strong track record for in-licensing and acquiring differentiated drugs, and for clinical development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $236.0M
- Funding stage: M&A
- Last round: Post-IPO Debt (Sep 2022)
- Ticker: nasdaq:SPPI
- Website: sppirx.com
- Phone: 9497886706
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/spectrum-pharmaceuticals-197959 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.